Features | Partner Sites | Information | LinkXpress
Sign In
Agfa Healthcare

Quantitative Susceptibility MR Imaging Developed to Monitor Multiple Sclerosis

By Medimaging International staff writers
Posted on 05 Jun 2014
Image: Dr. Ravi Menon, an imaging scientist at Western University’s Robarts Research Institute, used quantitative susceptibility MRI to show and measure damage in specific areas of the brain, which the study showed to be common to all MS and clinically isolated syndrome (CIS) patients (Photo courtesy of Western University).
Image: Dr. Ravi Menon, an imaging scientist at Western University’s Robarts Research Institute, used quantitative susceptibility MRI to show and measure damage in specific areas of the brain, which the study showed to be common to all MS and clinically isolated syndrome (CIS) patients (Photo courtesy of Western University).
Canadian imaging investigators have developed a better way to monitor the progression of multiple sclerosis (MS) at its earliest stages.

Led by Ravi Menon, PhD, from Western University’s Robarts Research Institute (London, Canada), the researchers used a new application called quantitative susceptibility (QS) magnetic resonance imaging (MRI), to gauge impairment in specific areas of the brain that the study showed to be common to all patients. The findings were published online May 28, 2014, in the journal Radiology.

“In MS research, there is something we call a clinical-radiological paradox. When you do conventional MRIs on these patients you see lesions in the brain very clearly, but the number or volume of their lesions do not correlate with the patients’ disabilities. This paradox has been recognized since the MRI was introduced to clinical practice in the early 80s, and yet this is the only imaging tool we have for assessing MS,” said Dr. Menon. “Our research provides a quantitative tool using a relatively conventional imaging sequence but with novel analysis. This tool shows that there is considerable damage occurring in common areas of all patients in both the white matter and in the deep brain structures—the gray matter. Those quantitative measures—what we call quantitative susceptibility—correlate with disease symptoms.”

The process used a conventional Siemens Healthcare (Erlangen, Germany) 3T MRI system so that it could be reproduced in any hospital, using the technique, called QS. The researchers mapped this MRI parameter in 25 patients with relapsing-remitting MS or clinically isolated syndrome (CIS; half of those diagnosed with CIS will go on to be diagnosed with MS) measuring both demyelination and iron deposition. Fifteen age- and sex-matched control study participants were also scanned. Whereas brain and spine lesions visualized with traditional MRI scanning tend to appear and disappear over time, QS revealed common areas of damage in all patients that correlated very well with the extended disability status score (EDSS), which is a standard approach used to measure MS progression, as well as with age and time since diagnosis.

“Significantly, in white matter, even where we see no lesions whatsoever, we’re able to measure damage in the same area of all patients using QS mapping. So even at the very earliest stages of the disease when the disability score is very low, or when the person hasn’t yet been diagnosed with MS, there’s already significant damage,” added Dr. Menon. This could have important diagnostic and prognostic implications, as there are drugs available to slow or stop the progression of MS, if initiated early enough.

Related Links:

Western University’s Robarts Research Institute
Siemens Healthcare



view channel
Image: Whole body images of a mouse before and after nanoparticles injections. Signal loss in the liver and the spleen due to the accumulation of iron from the nanoparticles is indicated by the red arrows. (Photo courtesy of Imperial College London).

Self-Assembling Nanoparticles Could Improve Cancer Diagnosis

Innovative nanoparticles boost the effectiveness of magnetic resonance imaging (MRI) scanning by specifically seeking out receptors that are found in cancerous cells. Developed by researchers at Imperial... Read more


view channel
Image: The Vivid T8 cardiovascular ultrasound system offers quantitative features such as stress echo and transesophageal echocardiography (TEE) capabilities (Photo courtesy of GE Healthcare).

Mobile, Cardiovascular Ultrasound Features Stress Echo and Transesophageal Echocardiography Capabilities

A 58.5-kg mobile cardiovascular ultrasound system features innovative quantitative features such as stress echo, and transesophageal echocardiography (TEE) capabilities, designed for healthcare providers... Read more

Nuclear medicine

view channel

Proton Therapy Has Better Outcome over IMRT for Advanced Head and Neck Cancers

Radiation oncologists compared the world’s literature on outcomes of proton beam therapy in the treatment of a range of advanced head and neck cancers of the skull base compared to intensity-modulated radiation therapy (IMRT) and found that proton beam therapy significantly improved disease-free survival and tumor control... Read more

General/Advanced Imaging

view channel
Image: Participant fitted with fNIRS headgear (Photo courtesy of University of Pittsburgh Schools of the Health Sciences).

Portable Optical Imaging Tool Designed for Concussion Evaluation

Researchers have demonstrated that a portable, low-cost optical imaging application is useful in evaluation of concussions. Two separate research projects, published recently, represent important steps... Read more

Imaging IT

view channel

Virtual Finger Helps Study 3D Images Faster

A new digital navigation technology allows users to sift through three-dimensional (3D) images more efficiently and comprehensively than previous technology. The Virtual Finger (VF), developed at the Allen Institute for Brain Science (Seattle, WA, USA), aids scientists and researchers move through digital images of small... Read more

Industry News

view channel

Hosting and Distribution Collaboration Established to Provide Radiation Dose Monitoring

PHS Technologies Group, LLC (Scottsdale, AZ, USA), a unit of PACSHealth, LLC, and a developer of software that monitors patient exposure to ionizing radiation, reported that Dell Healthcare and Life Sciences (Round Rock, TX, USA) will become a marketing, distribution, and hosting partner for its DoseMonitor OnLine software.... Read more
Copyright © 2000-2014 Globetech Media. All rights reserved.